Glycogen Synthase Kinase 3, antagonists & inhibitors

DBCAT001442Pharmacologic class

A DrugBank category of 6 drugs. 1 of them is approved.

What you can answer from here — as of August 24, 2016

6DrugsEach linked to its full drug card
Listed above
7Drug targetsEvery drug–target pair in the class, with bond type
Sign in

Which targets do Glycogen Synthase Kinase 3, antagonists & inhibitors share, and which companies have late-stage candidates in this class?

Create a free account or log in to explore the full data card.

Create Account